Q&A: Clomid Basics?

What is Clomid, and when should I go on it? What should I expect when I'm on it and how effective is it?
profile picture of Dr. Joseph Hill
ByDr. Joseph Hill
Cardiologist
Updated
Mar 2017
Hero Image

Clomid, or Clomiphene Citrate, is a medication the blocks the receptor for the female hormone estrogen. This causes the pituitary gland to secrete more follicle stimulating hormone (FSH), which in turn stimulates the ovary to make an egg.

This medication is useful in helping women who do not ovulate regularly to produce an egg every month, but has limited use in helping women who already ovulate become pregnant. If ovulation does not occur using this medication, there are others available that may. If the medication successfully  stimulates ovulation but more than four to six cycles go by without a pregnancy, other therapies should be attempted.

Ovulation is successfully stimulated with Clomid in up to 80% of women who do not otherwise ovulate, and 50% of these women become pregnant. Approximately 90% of the pregnancies achieved through Clomid occur within the first four cycles on the medication. 

Clomid is associated in some women with mood swings and depression, but both should go away once off the medication.

Related Video

Meet the World's First Baby Born After Uterus Transplant From Deceased Donor

Stephanie Grassullo
Associate Editor
Published
12/05/2018

Mom’s 'Dear Infertility' Letter Captures Her Agonizing Journey to Motherhood

Stephanie Grassullo
Associate Editor
Published
09/05/2018

One Question Could Help Doctors Learn More About Prenatal Health

Anisa Arsenault
Associate Editor
Published
02/09/2018

Q&A: Clomid Basics?

Dr. Joseph Hill
Cardiologist

Signs of Sperm Allergy?

Samuel Wood, MD
Reproductive Endocrinologist

Scientists Discover New Fertility Treatment

Leah Rocketto
Published
10/09/2012

What Is Tubal Ligation?

Lowell T. Ku, MD, reproductive endocrinologist, Dallas IVF
Fertility Specialist

UPDATE: Sofia Vergara Wins Second Embryo Battle Against Nick Loeb

Anisa Arsenault
Associate Editor
Published
08/31/2017
Advertisement